Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Managing Director at New Directions Technology Consulting, LLC
Napoleon Monroe is widely acknowledged as a subject matter expert on medication telemanagement and is the sole inventor of a portfolio of five U.S. and two international granted patents related to mHealth. His articles have been published in ONdrugDELIVERY, PDA Letter, PharmaVOICE and in conference proceedings. He has been active in the Parenteral Drug Association, American Telemedicine Association, Prescription for a Healthy America, Health IT Now, HIMSS, National Defense Industrial Association and other organizations.
Mr. Monroe regularly provides strategic and tactical advice to a wide range of commercial and not-for-profit organizations; helps companies, associations and educational organizations plan and host conferences; presents and moderates sessions at conferences; co-writes and edits the newsletter for a national trade association; and formally submits comments on policy, legislation and regulations.
His expertise includes product development, licensing, regulatory processes, risk management and international marketing, with experience managing business relationships in more than 30 countries.
Mr. Monroe's diversified background extends from developing and producing emergency pharmaceutical delivery systems to managing private brands for a Fortune 500 company, to building and managing the IP portfolio for a company that is now part of Pfizer.
As vice president of corporate brand development for global healthcare distribution and service company Henry Schein, Inc., Mr. Monroe was responsible for all aspects of the company's private brands. He grew annual sales by more than 500 percent to more than $500 million. While there, he also began filing medication telemanagement patents.
Before Henry Schein, Mr. Monroe spent more than 20 years at Survival Technology (now a part of Pfizer), where, as a corporate vice president, he was responsible for product development and systems strategy. While at Survival, he invented three medical devices that were patented and commercialized; two were for auto-injectors and one was for a transtelephonic, peak-flow monitoring device.
There, he also led teams that invented, prototyped, tested, commercialized and scaled up such products as: the original EpiPen, which became the basis for the leading product for treatment of anaphylactic shock; the Antidote Treatment Nerve Agent Auto-Injector delivery system, which still protects U.S. and allied military and civilian personnel; and products that supported the formation of Shahal Medical Services in Israel (acquired by Shanghai Jiuchuan) and Raytel (now part of Philips in the U.S.).